Skip navigation

 Login or Register | Member Centre

GlobeInvestorGOLD Canada's most comprehensive investment tool.

 
Change Symbol: Lookup Trade Now

Teva Pharmaceutical | Headlines

  • Vol:
  • Last Trade:
Search found 13 documents NextNext
1: Teva Receives Final Approval for Generic Prevacid® Delayed-Release Capsules
Business Wire, November 10, 2009 04:17 PM

2: Teva Receives Favorable Court Decision Regarding Generic Prevacid® SoluTab
Business Wire, November 10, 2009 09:46 AM

3: Teva Files Amended Complaint Against Momenta/Sandoz to Include Infringement of Three COPAXONE®-Related Patents
Business Wire, November 10, 2009 02:01 AM

4: Teva Introduces Fexofenadine HCl and Pseudoephedrine HCl Extended-Release Tablets; An Alternative to Allegra-D® 12 Hour Tablets
Business Wire, November 3, 2009 03:35 PM

5: Teva Reports Third Quarter 2009 Results
Business Wire, November 3, 2009 01:30 AM

6: A.T. Kearney Releases 2009 Ranking of Global Champions
PR NEWSWIRE, October 15, 2009 12:21 PM

7: Study Demonstrates That QVAR(R) is More Cost-Effective Than Other Inhaled Corticosteroid (ICS) Asthma Therapy Options
PR NEWSWIRE, September 16, 2009 08:10 AM

8: Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ
PR NEWSWIRE, August 3, 2009 12:53 PM

9: Menopause Is More Than A Hot Flash
PR NEWSWIRE, July 15, 2009 08:00 AM

10: U.S. Federal Trade Commission Clears Teva's Acquisition of Barr
PR NEWSWIRE, December 19, 2008 03:00 PM

NextNext
 

Search using one or more of the following options:

Symbol Lookup
 
 
  Search Tips
 
  * Can only be used when searching The Globe and Mail and newswires.

Back to top